Concepedia

Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent

Michael R. Myers, Wei He, Barbara Hanney, Natalie N. Setzer, Martin P. Maguire, Allison L. Zulli, Glenda E. Bilder, Helen Galzcinski, Dilip Amin, Saul Needle,

Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · 6 references

DOIFull text

Open access

Concepts

References

6

An Improved Catalyst System for Aromatic Carbon−Nitrogen Bond Formation:  The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates

John P. Wolfe, Seble Wagaw, Stephen L. Buchwald · Journal of the American Chemical Society · 1996 · 603 citations

, , +12

A New Series of PDGF Receptor Tyrosine Kinase Inhibitors: 3-Substituted Quinoline Derivatives

Martin P. Maguire, Kimberly R. Sheets, Karen McVety et al. · Journal of Medicinal Chemistry · 1994 · 440 citations · Full text

, , +12

Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511A

Glenda E. Bilder, Tara Wentz, Robert J. Leadley et al. · Circulation · 1999 · 88 citations

, , +15

Small molecule inhibitors of receptor tyrosine kinases

Diane H. Boschelli · Drugs of the Future · 1999 · 70 citations

, , +14

Potent Noncovalent Thrombin Inhibitors That Utilize the Unique Amino Acid <scp>d</scp>-Dicyclohexylalanine in the P3 Position. Implications on Oral Bioavailability and Antithrombotic Efficacy

Thomas J. Tucker, William C. Lumma, Sidney D. Lewis et al. · Journal of Medicinal Chemistry · 1997 · 58 citations · Full text

, , +12